A PDF is not on file for this bill — the text is shown below instead.
Senate Judiciary
May 30, 2023
2023-2060s
07/05
Amendment to HB 287-FN
Amend the title of the bill by replacing it with the following:
AN ACT removing fentanyl and xylazine testing equipment from the definition of drug paraphernalia in the controlled drug act.
Amend the bill by replacing all after the enacting clause with the following:
1 New Paragraph; Occupations and Professions; Controlled Drug Act; Definitions. Amend RSA 318-B:1 by inserting after paragraph X-a the following new paragraph:
X-b. Notwithstanding the provisions of RSA 318-B:1, X-a, “drug paraphernalia” shall not include fentanyl test strips, xylazine test strips, or other materials used or intended for use in testing for the presence of fentanyl, xylazine, or a fentanyl or xylazine analog in a substance, unless possessed in conjunction with other evidence forming the basis of a criminal charge involving the manufacturing, possessing with the intent to sell, or compounding pursuant to RSA 318-B:2, I.
2 Effective Date. This act shall take effect 60 days after its passage.
2023-2060s
AMENDED ANALYSIS
This bill removes fentanyl and xylazine testing paraphernalia in certain instances from the definition of drug paraphernalia in the controlled drug act.